ALEMBIC
Back to Balance Sheet
|
ALEMBIC Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹2,520 Cr | ₹2,335 Cr | ₹2,210 Cr | ₹2,632 Cr | ₹2,409 Cr |
What is the latest Total Liabilities ratio of ALEMBIC ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹2,520 Cr |
Mar2024 | ₹2,335 Cr |
Mar2023 | ₹2,210 Cr |
Mar2022 | ₹2,632 Cr |
Mar2021 | ₹2,409 Cr |
How is Total Liabilities of ALEMBIC Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹2,520 Cr | 7.95 | |
Mar2024 | ₹2,335 Cr | 5.62 | |
Mar2023 | ₹2,210 Cr | -16.02 | |
Mar2022 | ₹2,632 Cr | 9.26 | |
Mar2021 | ₹2,409 Cr | - |
Compare Total Liabilities of peers of ALEMBIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC | ₹2,663.0 Cr | -3.9% | -9.8% | -36% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹384,002.0 Cr | -2.1% | -5.8% | -6.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,334.0 Cr | 3.1% | -6.5% | 28.7% | Stock Analytics | |
CIPLA | ₹127,613.0 Cr | 2.2% | 3.2% | 1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,923.0 Cr | -1.7% | NA | 9.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,437.0 Cr | 1.4% | -1.1% | -7.6% | Stock Analytics |
ALEMBIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC | -3.9% |
-9.8% |
-36% |
SENSEX | -1.1% |
-1.7% |
-0.3% |
You may also like the below Video Courses